STOCK TITAN

[Form 4] Aehr Test Systems Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Aehr Test Systems (AEHR) – Form 4 insider activity: Chief Financial Officer Chris Siu reported several equity transactions dated 07/02/2025.

  • Acquisitions: 30,998 and 5,586 common shares acquired at $0 per share through the vesting of restricted stock units (RSUs).
  • Disposition: 752 shares automatically withheld at $15.13 to cover tax obligations (transaction code “F” – not an open-market sale).
  • Resulting ownership: 77,623 directly held shares after the transactions, plus 4,202 shares held indirectly via a trust.
  • Vesting schedule notes indicate quarterly vesting over up to four years; unvested RSUs remain outstanding.

The filing increases the CFO’s direct ownership by roughly 35.8 thousand shares, reinforcing management’s equity stake. No cash purchases or discretionary sales were reported, suggesting the activity is routine compensation-related rather than a signal of changing outlook.

Aehr Test Systems (AEHR) – Attività interna Form 4: Il Chief Financial Officer Chris Siu ha riportato diverse operazioni azionarie datate 02/07/2025.

  • Acquisizioni: 30.998 e 5.586 azioni ordinarie acquisite a 0 $ per azione tramite il vesting di unità azionarie vincolate (RSU).
  • Disposizione: 752 azioni trattenute automaticamente a 15,13 $ per coprire obblighi fiscali (codice transazione “F” – non una vendita sul mercato aperto).
  • Proprietà risultante: 77.623 azioni detenute direttamente dopo le transazioni, più 4.202 azioni detenute indirettamente tramite un trust.
  • Le note sul piano di vesting indicano un vesting trimestrale fino a un massimo di quattro anni; le RSU non maturate rimangono in essere.

La dichiarazione aumenta la proprietà diretta del CFO di circa 35,8 mila azioni, rafforzando la partecipazione azionaria della direzione. Non sono stati segnalati acquisti in contanti o vendite discrezionali, suggerendo che l’attività è di routine legata alla compensazione e non un segnale di cambiamento nelle prospettive.

Aehr Test Systems (AEHR) – Actividad interna Formulario 4: El Director Financiero Chris Siu reportó varias transacciones de acciones fechadas el 02/07/2025.

  • Adquisiciones: 30.998 y 5.586 acciones comunes adquiridas a $0 por acción mediante la consolidación de unidades restringidas de acciones (RSU).
  • Disposición: 752 acciones retenidas automáticamente a $15.13 para cubrir obligaciones fiscales (código de transacción “F” – no es una venta en mercado abierto).
  • Propiedad resultante: 77.623 acciones en propiedad directa tras las transacciones, más 4.202 acciones mantenidas indirectamente a través de un fideicomiso.
  • Las notas del calendario de consolidación indican consolidación trimestral durante hasta cuatro años; las RSU no consolidadas permanecen vigentes.

El informe incrementa la propiedad directa del CFO en aproximadamente 35,8 mil acciones, reforzando la participación accionaria de la gerencia. No se reportaron compras en efectivo ni ventas discrecionales, lo que sugiere que la actividad es rutinaria y relacionada con la compensación, no una señal de cambio en las perspectivas.

Aehr Test Systems (AEHR) – Form 4 내부자 거래 활동: 최고재무책임자 Chris Siu가 2025년 7월 2일자 여러 주식 거래를 보고했습니다.

  • 취득: 제한 주식 단위(RSU)의 베스팅을 통해 주당 0달러에 30,998주 및 5,586주의 보통주를 취득했습니다.
  • 처분: 세금 의무를 충당하기 위해 752주가 주당 15.13달러로 자동 원천징수되었습니다(거래 코드 “F” – 공개 시장 매도 아님).
  • 거래 후 보유 주식: 거래 후 직접 보유 주식 77,623주, 신탁을 통해 간접 보유한 주식 4,202주입니다.
  • 베스팅 일정 메모에 따르면 최대 4년 동안 분기별 베스팅이 있으며, 베스팅되지 않은 RSU는 여전히 유효합니다.

이번 신고로 CFO의 직접 보유 주식이 약 35,800주 증가하여 경영진의 지분이 강화되었습니다. 현금 구매나 임의 매도는 보고되지 않아, 이 활동이 전망 변화의 신호가 아닌 보상 관련 일상적인 거래임을 시사합니다.

Aehr Test Systems (AEHR) – Activité d’initié Formulaire 4 : Le directeur financier Chris Siu a déclaré plusieurs transactions sur actions datées du 02/07/2025.

  • Acquisitions : 30 998 et 5 586 actions ordinaires acquises à 0 $ par action via l’acquisition progressive d’unités d’actions restreintes (RSU).
  • Disposition : 752 actions retenues automatiquement à 15,13 $ pour couvrir les obligations fiscales (code de transaction « F » – pas une vente sur le marché ouvert).
  • Propriété résultante : 77 623 actions détenues directement après les transactions, plus 4 202 actions détenues indirectement via un trust.
  • Les notes sur le calendrier d’acquisition indiquent une acquisition trimestrielle sur une période allant jusqu’à quatre ans ; les RSU non acquises restent en cours.

Le dépôt augmente la détention directe du directeur financier d’environ 35,8 milliers d’actions, renforçant la participation en actions de la direction. Aucun achat en espèces ni vente discrétionnaire n’a été signalé, ce qui suggère que l’activité est liée à la rémunération habituelle plutôt qu’à un changement de perspective.

Aehr Test Systems (AEHR) – Insider-Aktivität Form 4: Chief Financial Officer Chris Siu meldete mehrere Aktiengeschäfte vom 02.07.2025.

  • Erwerbe: 30.998 und 5.586 Stammaktien wurden zu je 0 $ durch die Vesting von Restricted Stock Units (RSUs) erworben.
  • Veräußerung: 752 Aktien wurden automatisch zu 15,13 $ einbehalten, um Steuerverpflichtungen zu decken (Transaktionscode „F“ – kein Verkauf am offenen Markt).
  • Ergebnis des Besitzes: Nach den Transaktionen direkt gehaltene 77.623 Aktien plus 4.202 Aktien, die indirekt über einen Trust gehalten werden.
  • Hinweise zum Vesting-Plan zeigen vierteljährliches Vesting über bis zu vier Jahre; nicht vestete RSUs bleiben ausstehend.

Die Meldung erhöht den direkten Besitz des CFO um etwa 35,8 Tausend Aktien und stärkt somit die Beteiligung des Managements. Es wurden keine Barankäufe oder diskretionären Verkäufe gemeldet, was darauf hindeutet, dass die Aktivität routinemäßig vergütungsbedingt ist und kein Zeichen für eine geänderte Perspektive darstellt.

Positive
  • CFO increased direct share ownership by approximately 35,832 shares, demonstrating continued equity alignment with shareholders.
Negative
  • None.

Insights

TL;DR: Routine RSU vesting; CFO adds ≈35.8k shares, minimal market impact.

The Form 4 reflects standard compensation mechanics rather than an opportunistic buy or sell. The zero-cost acquisitions are RSU conversions, while the 752-share disposition is a tax-withholding entry. Post-filing direct ownership rises to 77,623 shares, a modest but positive alignment indicator. However, given AEHR’s 28 million+ shares outstanding, the incremental ownership (<0.15%) is immaterial. I view the disclosure as neutral to the investment thesis.

TL;DR: Compensation-driven insider activity, governance-neutral.

All transactions stem from pre-approved equity awards. The presence of a Rule 10b5-1 checkbox confirms adherence to structured trading plans, limiting governance risk. No discretionary selling occurred, which avoids negative optics. The insider’s growing stake is modestly shareholder-friendly, but not large enough to alter control dynamics or signalling value. Overall impact on investors is negligible.

Aehr Test Systems (AEHR) – Attività interna Form 4: Il Chief Financial Officer Chris Siu ha riportato diverse operazioni azionarie datate 02/07/2025.

  • Acquisizioni: 30.998 e 5.586 azioni ordinarie acquisite a 0 $ per azione tramite il vesting di unità azionarie vincolate (RSU).
  • Disposizione: 752 azioni trattenute automaticamente a 15,13 $ per coprire obblighi fiscali (codice transazione “F” – non una vendita sul mercato aperto).
  • Proprietà risultante: 77.623 azioni detenute direttamente dopo le transazioni, più 4.202 azioni detenute indirettamente tramite un trust.
  • Le note sul piano di vesting indicano un vesting trimestrale fino a un massimo di quattro anni; le RSU non maturate rimangono in essere.

La dichiarazione aumenta la proprietà diretta del CFO di circa 35,8 mila azioni, rafforzando la partecipazione azionaria della direzione. Non sono stati segnalati acquisti in contanti o vendite discrezionali, suggerendo che l’attività è di routine legata alla compensazione e non un segnale di cambiamento nelle prospettive.

Aehr Test Systems (AEHR) – Actividad interna Formulario 4: El Director Financiero Chris Siu reportó varias transacciones de acciones fechadas el 02/07/2025.

  • Adquisiciones: 30.998 y 5.586 acciones comunes adquiridas a $0 por acción mediante la consolidación de unidades restringidas de acciones (RSU).
  • Disposición: 752 acciones retenidas automáticamente a $15.13 para cubrir obligaciones fiscales (código de transacción “F” – no es una venta en mercado abierto).
  • Propiedad resultante: 77.623 acciones en propiedad directa tras las transacciones, más 4.202 acciones mantenidas indirectamente a través de un fideicomiso.
  • Las notas del calendario de consolidación indican consolidación trimestral durante hasta cuatro años; las RSU no consolidadas permanecen vigentes.

El informe incrementa la propiedad directa del CFO en aproximadamente 35,8 mil acciones, reforzando la participación accionaria de la gerencia. No se reportaron compras en efectivo ni ventas discrecionales, lo que sugiere que la actividad es rutinaria y relacionada con la compensación, no una señal de cambio en las perspectivas.

Aehr Test Systems (AEHR) – Form 4 내부자 거래 활동: 최고재무책임자 Chris Siu가 2025년 7월 2일자 여러 주식 거래를 보고했습니다.

  • 취득: 제한 주식 단위(RSU)의 베스팅을 통해 주당 0달러에 30,998주 및 5,586주의 보통주를 취득했습니다.
  • 처분: 세금 의무를 충당하기 위해 752주가 주당 15.13달러로 자동 원천징수되었습니다(거래 코드 “F” – 공개 시장 매도 아님).
  • 거래 후 보유 주식: 거래 후 직접 보유 주식 77,623주, 신탁을 통해 간접 보유한 주식 4,202주입니다.
  • 베스팅 일정 메모에 따르면 최대 4년 동안 분기별 베스팅이 있으며, 베스팅되지 않은 RSU는 여전히 유효합니다.

이번 신고로 CFO의 직접 보유 주식이 약 35,800주 증가하여 경영진의 지분이 강화되었습니다. 현금 구매나 임의 매도는 보고되지 않아, 이 활동이 전망 변화의 신호가 아닌 보상 관련 일상적인 거래임을 시사합니다.

Aehr Test Systems (AEHR) – Activité d’initié Formulaire 4 : Le directeur financier Chris Siu a déclaré plusieurs transactions sur actions datées du 02/07/2025.

  • Acquisitions : 30 998 et 5 586 actions ordinaires acquises à 0 $ par action via l’acquisition progressive d’unités d’actions restreintes (RSU).
  • Disposition : 752 actions retenues automatiquement à 15,13 $ pour couvrir les obligations fiscales (code de transaction « F » – pas une vente sur le marché ouvert).
  • Propriété résultante : 77 623 actions détenues directement après les transactions, plus 4 202 actions détenues indirectement via un trust.
  • Les notes sur le calendrier d’acquisition indiquent une acquisition trimestrielle sur une période allant jusqu’à quatre ans ; les RSU non acquises restent en cours.

Le dépôt augmente la détention directe du directeur financier d’environ 35,8 milliers d’actions, renforçant la participation en actions de la direction. Aucun achat en espèces ni vente discrétionnaire n’a été signalé, ce qui suggère que l’activité est liée à la rémunération habituelle plutôt qu’à un changement de perspective.

Aehr Test Systems (AEHR) – Insider-Aktivität Form 4: Chief Financial Officer Chris Siu meldete mehrere Aktiengeschäfte vom 02.07.2025.

  • Erwerbe: 30.998 und 5.586 Stammaktien wurden zu je 0 $ durch die Vesting von Restricted Stock Units (RSUs) erworben.
  • Veräußerung: 752 Aktien wurden automatisch zu 15,13 $ einbehalten, um Steuerverpflichtungen zu decken (Transaktionscode „F“ – kein Verkauf am offenen Markt).
  • Ergebnis des Besitzes: Nach den Transaktionen direkt gehaltene 77.623 Aktien plus 4.202 Aktien, die indirekt über einen Trust gehalten werden.
  • Hinweise zum Vesting-Plan zeigen vierteljährliches Vesting über bis zu vier Jahre; nicht vestete RSUs bleiben ausstehend.

Die Meldung erhöht den direkten Besitz des CFO um etwa 35,8 Tausend Aktien und stärkt somit die Beteiligung des Managements. Es wurden keine Barankäufe oder diskretionären Verkäufe gemeldet, was darauf hindeutet, dass die Aktivität routinemäßig vergütungsbedingt ist und kein Zeichen für eine geänderte Perspektive darstellt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Siu Chris

(Last) (First) (Middle)
C/O AEHR TEST SYSTEMS
400 KATO TERRACE

(Street)
FREMONT CA 94539

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/02/2025 A 30,998(1) A $0 72,789 D
Common Stock 07/02/2025 A 5,586(2) A $0 78,375 D
Common Stock 07/02/2025 F 752(3) D $15.13 77,623(4) D
Common Stock 4,202 I By Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates.
2. 25% of shares subject to the restricted stock unit awards shall vest immediately and the remaining 75% of shares will vest quarterly over the remaining 3 years.
3. Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.
4. The amount reported includes shares subject to unvested restricted stock units.
Remarks:
/s/SIU CHRIS 07/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AEHR shares does CFO Chris Siu now own?

After the 07/02/2025 transactions, he holds 77,623 directly owned shares plus 4,202 indirect shares held by a trust.

Were any AEHR shares sold on the open market?

No. The only disposition was 752 shares withheld at $15.13 solely to cover taxes; no open-market sale occurred.

What type of insider transactions were reported?

The filing shows restricted stock unit (RSU) vesting acquisitions at no cost and a small tax-withholding disposition.

Does this Form 4 indicate a Rule 10b5-1 trading plan?

Yes, the form includes the checkbox indicating transactions made pursuant to a Rule 10b5-1(c) plan.

Is the ownership change material to AEHR investors?

The added shares represent less than 0.15% of AEHR’s outstanding shares, so the market impact is minimal.
Aehr Test Sys

NASDAQ:AEHR

AEHR Rankings

AEHR Latest News

AEHR Latest SEC Filings

AEHR Stock Data

379.59M
28.11M
5.06%
72.02%
24.14%
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
FREMONT